Clinical Trial Update: A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the timing of pembrolizumab around surgery in high-risk melanoma, comparing post-operative administration to strategies including pre- …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acral Lentiginous Melanoma
• Cutaneous Melanoma
• Mucosal Melanoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acral Lentiginous Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8 | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-11-21